Warning: There are an increasing number of fraudulent websites that impersonate the ECCMID. We would like to alert all our members and delegates to be aware of possible scams and to strongly advise you to only use the official ECCMID online registration and accommodation services for your bookings.

Educational Workshops

Remaining issues in hepatitis C
Overview of current therapy in hepatitis C
Retreatment and resistance
Transplantation of HCV-infected organs into uninfected recipients
Residual problems after cure
Co-arranged with ESGVH - ESCMID SG for Viral Hepatitis

Emerging neurotropic viruses of clinical significance
(Re-) emerging neurotropic viruses of clinical significance
Neurotropic virus diagnostics
Clinical case scenarios – interactive session
Interactive panel discussion
Co-arranged with PREPARE

HIV/AIDS in 2018: where are we and where are we going?
Current epidemiology of HIV-infection in Eastern European countries: a triple deadly
HIV, HCV and TB combination
New strategies on antiretroviral therapy in 2018: from triple to dual therapy?
PrEP in real life
Functional cure vs. eradication: will it be feasible?
Co-arranged with European AIDS Clinical Society

The case for screening for tuberculosis
Issues in screening for latent tuberculosis
Screening for active tuberculosis: who, when and how?
Pre-migration screening for TB
The special case of screening hard-to-reach migrants

ESCMID guideline on the management of infections due to MDR Gram-negative bacteria - a case-based discussion
Short introduction
Case presentations and panel discussion

Update on sexually transmitted infections
Social media and its impact on sexually transmitted infections
Genital-anal-oral ulcer disease update
Sexually transmitted infections in pregnancy and congenital infections
Self-collected samples for the diagnosis of sexually transmitted infections

Current issues in Lyme borreliosis
Epidemiology and clinical presentation of Lyme borreliosis 
Role of serology, culture and PCR 
Biomarkers for Lyme neuroborreliosis Key messages from the Lyme disease guideline update
Co-arranged with ESGBOR - ESCMID SG for Lyme Borreliosis, Infectious Diseases Society of America (IDSA)

Diagnostic stewardship in practice
Diagnostic stewardship in clinical microbiology
The importance of the gatekeeper for indication of diagnostics
Diagnostic stewardship in high-throughput diagnostics
Interactive panel discussion

Expediting antibacterial development: core lessons and key tools for a rocky road
EU regulatory tools for expedited antibacterial development programmes
US regulatory tools for expedited antibacterial development programmes
PK-PD in support of accelerated programmes: how much is enough?
Alternatives to (classical) antibiotics: what will it take to convincingly develop a virulence inhibitor or similar indirect agent?
Interactive panel discussion
Co-arranged with Global Antibiotic Research & Development Partnership (GARD-P), Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)

Fungal infections in the neonatal and paediatric population
Risk factors and clinical manifestations of fungal infections in neonates and paediatric patients
Candida and other yeast infections: epidemiology data and diagnostic options for neonates and paediatric patients
Prevention of Candida transmission - a multifaceted issue
Interactive panel discussion
Co-arranged with Serbian Society of Medical Mycology

It’s Saturday morning and we have a yeast in the blood culture in a patient with cancer
An interactive case of unexpected candidiasis
Treatment - directed by susceptibility or resistance?
Diagnosis - is culture enough?
Interactive panel discussion
Co-arranged with European Organisation for Research and Treatment of Cancer (EORTC), EFISG - ESCMID Fungal Infection SG, ESGCIP - ESCMID SG for Infections in Critically Ill Patients

Syndromic approach to returning travellers
Fever in returned travellers
Skin problems in returned travellers
Eosinophilia in returned travellers
Diarrhoea in returned travellers
Co-arranged with ESGCP - ESCMID SG for Clinical Parasitology, ESGITM - ESCMID SG for Infections in Travellers and Migrants

Zoonoses - current and future concerns
Rickettsiosis/scrub typhus
Cystic echinococcosis
Interactive panel discussion
Co-arranged with ESGCP - ESCMID SG for Clinical Parasitology

Controversies in C. difficile infection control
CDI cases - to isolate or not to isolate?
What is the role of the asymptomatic carrier in environmental contamination with C. difficile spores and nosocomial transmission, and can we do anything to prevent it?
Enhanced deep cleaning/disinfection in hyperendemic areas – the way to go to prevent transmission?
Interactive panel discussion
Co-arranged with ESGNI - ESCMID SG for Nosocomial Infections, ESGCD - ESCMID SG for Clostridium difficile

Is decolonization the last chance to overcome antimicrobial resistance?
New ESCMID guidelines on decolonization
New drugs selectively changing the microbiome without disrupting its functions - is it possible?
New guidelines on ventilator-associated pneumonia
Interactive panel discussion
Co-arranged with EUCIC – European Committee on Infection Control

Career development for the next generation of CM/ID professionals
Next-generation sequencing and the next generation of microbiologists
What is the future with antimicrobial stewardship?
What can be my role in infection control?
Interactive panel discussion
Co-arranged with TAE – Trainees Association of ESCMID, ESGMD - ESCMID SG for Genomic and Molecular Diagnostics, ESGAP - ESCMID SG for Antimicrobial stewardshiP, UEMS Section of Infectious Diseases, UEMS Section of Medical Microbiology

Common standards and guidelines for whole-genome sequencing (WGS) of microbial pathogens in routine epidemiology
The MRC-CLIMB project: cloud computing as a community resource for microbial genomics
The importance of transparent boxes: need for reproducible and certifiable solutions for high-throughput sequencing analysis in routine epidemiology
The importance of standards: from ontologies to reporting forms and visualization techniques
Building pipelines for genomics and molecular epidemiology: from academia to public health
Co-arranged with ESGEM - ESCMID SG for Epidemiological Markers

Hot topics on methods for clinical research in infectious diseases
Tips to develop high level observational studies
How to make trials efficient: adaptative designs
Designing before-after studies to build evidence
Interactive panel discussion
Co-arranged with ESGBIS - ESCMID SG for Bloodstream Infections and Sepsis

Tropical diseases and travel medicine in solid organ transplant (SOT) recipients
Arboviruses in SOT
Nematodes and protozoan infections in SOT
Transplant tourism and healthcare infections (an approach in MDR infections)Interactive panel discussion
Co-arranged with ESGITM - ESCMID SG for Infections in Travellers and Migrants, ESGICH - ESCMID SG for Infections in Compromised Hosts

Antimicrobial susceptibility testing with EUCAST breakpoints and methods
What is new in EUCAST?
Carbapenem and aminoglycoside breakpoints revisited
Expert rules - finally there
Standardisation of antimicrobial susceptibility testing of M. tuberculosis
Rapid AST with disk diffusion on direct inoculation from blood culture bottles
Implementing breakpoints outside Europe
Susceptibility testing of anaerobic bacteria
Interactive panel discussion
Co-arranged with EUCAST - European Committee on Antimicrobial Susceptibility Testing

Hands-on infection control - what does actually work to prevent infections?
The standard of care for infection control in 2018 
Before an outbreak - surveillance, data management and alerts in infection control
Before an outbreak - is complete sanitation of robotic surgical instruments possible?
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital?
During an outbreak - whole-genome sequencing to enhance infection control effectiveness
During an outbreak - application of mathematical modelling in infection control
During an outbreak - dealing with the media and support mechanisms for healthcare professionals during outbreaks
After an outbreak - do we have to accept “endemicity” without fighting back?
After an outbreak - Mycobacterium chimera: under control or under water?
Co-arranged with EUCIC – European Committee on Infection Control